NASH - Nonalcoholic Steatohepatitis
Infectious Disease·MeSH: Non-alcoholic Fatty Liver Disease
Prevalence
5000.0 / 100K
Incidence
500.0 / 100K/yr
10 drugs in development·8 companies·11 clinical trials
Drug Pipeline by Phase
Phase 3(4)
Compare drugs
Frequently asked questions
How many drugs are in development for NASH - Nonalcoholic Steatohepatitis?
BioSniper tracks 10 drugs in development for NASH - Nonalcoholic Steatohepatitis across 8 companies.
How many clinical trials target NASH - Nonalcoholic Steatohepatitis?
There are 11 clinical trials targeting NASH - Nonalcoholic Steatohepatitis tracked by BioSniper.
What is the prevalence of NASH - Nonalcoholic Steatohepatitis?
The estimated prevalence of NASH - Nonalcoholic Steatohepatitis is approximately 5000.0 per 100,000 population.
Deep-dive into NASH - Nonalcoholic Steatohepatitis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis